Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Patent Issued

4 Jul 2018 07:00

RNS Number : 5006T
AorTech International PLC
04 July 2018
 

 4 July 2018 

AorTech International plc 

("AorTech" or the "Company") 

  

New Patent Issued

 

AorTech is pleased to announce that the Brazilian Patent Office has recently granted Patent Number PI 0711694-2 entitled Biostable Gels. The invention relates to biostable gels, the processes for their preparation and their use in the manufacture and repair of biomaterials and medical devices or implants, in particular soft tissue implants such as breast implants.

 

Bill Brown, Chairman of AorTech said: "The issue of this patent further expands AorTech's patent portfolio, particularly in the area of breast implants. Brazil is one of the largest markets for breast enhancement outside of the USA and is therefore an important patent territory. The portfolio of IP relating to Breast Implants is not currently licensed by AorTech."

  

For further information contact: 

  

AorTech International plc Tel: +44 (0)7730 718296  

Bill Brown, Chairman  

  

Stockdale Securities Limited Tel: +44 (0)20 7601 6100  

Tom Griffiths/David Coaten  

  

About AorTech: 

  

AorTech has developed biostable, implantable polymers, including Elast-Eon™ and ECSil™ the world's leading long-term implantable co-polymers, now manufactured on their behalf by Biomerics LLC in Utah, USA. With several million implants and seven years of successful clinical use, AorTech polymers are being developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. Devices manufactured from AorTech polymers have numerous US FDA PMA approvals, 510ks, CE Marks, Australian TGA and Japanese Ministry of Health approvals. 

  

Elast-Eon™ and ECSil™'s biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. A range of materials in a variety of application-specific formulations for use in medical devices and components are available.

 

In addition to the licensing of biostable polymers, AorTech is now developing medical devices utilizing the key properties of its world class polymers.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDLLFERDVIVIIT
Date   Source Headline
9th Oct 20131:55 pmRNSDirector/PDMR Shareholding
8th Oct 20132:56 pmRNSDirector/PDMR Shareholding
8th Oct 20137:00 amRNSSettlement of Legal Proceedings
1st Oct 20138:18 amRNSNew Manufacture License
27th Sep 20138:37 amRNSResult of AGM
28th Aug 20137:00 amRNSFinal Results
23rd May 201312:23 pmRNSUpdate and appointment of director
20th Mar 20139:39 amRNSCommencement of legal proceedings
27th Dec 20127:00 amRNSHalf Yearly Report
24th Dec 20128:35 amRNSDispute with St Jude Medical resolved
5th Nov 20121:31 pmRNSUpdate re litigation
26th Oct 20123:47 pmRNSIssue of loan notes
22nd Oct 20129:15 amRNSUpdate
19th Oct 20122:43 pmRNSUpdate re St Jude
18th Oct 20124:39 pmRNSUpdate re St Jude
9th Oct 20128:02 amRNSRe Agreement
28th Sep 201211:29 amRNSUpdate
10th Sep 20122:51 pmRNSForm 8.3 - AorTech Inter PLC
4th Sep 20127:00 amRNSFinal Results
13th Aug 201210:03 amRNSUpdate on sale process
26th Jul 20125:16 pmRNSForm 8.3 - AorTech International plc
23rd Jul 20123:08 pmRNSForm 8 (OPD) (AorTech International Plc)
23rd Jul 20121:46 pmRNSForm 8.3 - [AorTech Inter PLC]
18th Jul 201210:53 amRNSForm 8.3 - AorTech International PLC
13th Jul 201210:37 amRNSForm 8.3 - [AorTech Inter PLC]
12th Jul 20122:06 pmRNSForm 8.3 - AorTech International PLC
11th Jul 20124:06 pmRNSForm 8.3 - AorTech International PLC
10th Jul 20123:04 pmRNSForm 8.3 - [AorTech International PLC]
10th Jul 201212:09 pmRNSForm 8.3 - Aortech Intl Plc
10th Jul 201212:08 pmRNSForm 8.3 Aortech Intl Plc
10th Jul 201211:54 amRNSForm 8 (OPD) Aortech Intl Plc
10th Jul 201210:38 amRNSForm 8.3 - [AorTech International PLC]
4th Jul 20122:06 pmRNSForm 8.3 - Aortech International plc
4th Jul 20121:23 pmRNSForm 8.3 - Aortech International Plc
3rd Jul 20127:00 amRNSBoard Change & Strategic Update
23rd Apr 20127:00 amRNSChange of Nominated Adviser
6th Mar 20123:30 pmRNSAorTech Announces Update of Factory Move
25th Jan 20123:08 pmRNSHolding(s) in Company
14th Dec 201110:48 amRNSAorTech Announces Interim Report (Replacement)
14th Dec 20117:00 amRNSAorTech Announces Interim Report
18th Nov 20117:00 amRNSAorTech Announces Exclusive Licence in New Field
21st Oct 20117:00 amRNSDirectorate Change
9th Sep 20117:00 amRNSResult of AGM
8th Sep 20119:30 amRNSAorTech Announces Breast Implant Agreement
18th Aug 20115:00 pmRNSNotice of AGM
15th Aug 20116:03 pmRNSDirector/PDMR Shareholding
3rd Aug 20117:00 amRNSDirectorate Change
1st Aug 20117:00 amRNSAorTech Announces Year End Preliminary Results
16th Jun 20117:00 amRNSAorTech to Open US Facility
20th May 20119:09 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.